Homeopathic Treatment of Overweight and Obesity in Pregnant Women With Mental Disorders: A Double-blind, Controlled Clinical Trial

Imagem de Miniatura
Arquivos
art_VILHENA_Homeopathic_Treatment_of_Overweight_and_Obesity_in_Pregnant_2016.PDF (444.96 KB)
Citações na Scopus
4
Tipo de produção
article
Data de publicação
2016
Scopus
Web of Science
PubMed
Título da Revista
ISSN da Revista
Título do Volume
Editora
INNOVISION COMMUNICATIONS
Autores
VILHENA, Edgard Costa de
Citação
ALTERNATIVE THERAPIES IN HEALTH AND MEDICINE, v.22, suppl.3, p.14-22, 2016
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Context Worldwide, 35 million people suffer from obesity. Mental disorders have been associated with being overweight or obese. Considerable evidence has shown a correlation between stress and the use of homeopathy and stress and obesity. However, few studies have examined the relationship between weight loss and homeopathic treatment of obesity. Objective The study intended to evaluate the efficacy of a homeopathic treatment in preventing excessive weight gain during pregnancy in overweight or obese women who were suspected of having a common mental disorder. Design The study was a randomized, controlled, double-blinded clinical trial. Setting The study took place at the Center for the Social Support of Motherhood (Sao Paulo, Brazil). Participants Participants were pregnant women who were enrolled at the center. Intervention For the homeopathic group, 9 drugs were preselected, including (1) Pulsatilla nigricans, (2) Sepia succus, (3) Lycopodium clavatum, (4) sulphur, (5) Lachesis trigonocephalus, (6) Nux vomica, (7) Calcarea carbonica, (8) phosphorus; and (9) Conium maculatum. From those 9 drugs, 1 was prioritized for administration for each participant. After the first appointment, a reselection or selection of a new, more appropriate drug occurred, using the list of preselected drugs. The dosage was 6 drops orally 2 x/d, in the morning and at night, on 4 consecutive days each wk, with an interval of 3 d between doses, up until the next appointment medical appointment. The control group received the equivalent placebo drug. Both groups also received a diet orientation. Outcome Measures We evaluated pregnant women who were overweight or had class 1 or 2 obesity and were suspected of having a common mental disorder, with no concomitant diseases, in 2 groups: those receiving a placebo (control group, n = 72); and those receiving homeopathic treatment (homeopathy group, n = 62). Weight change during pregnancy was defined as the difference between the body mass index (BMI) at the initial evaluation and that recorded at the final evaluation, adjusted for 40 wk of gestation. In addition, the APGAR index in the newborn was evaluated as a possible complication. Results The mean variation between baseline BMI and BMI at week 40 of gestation was + 4.95 kg/m(2) in the control group and + 5.05 kg/m(2) in the homeopathy group. The difference between the 2 groups was not significant (P = .815; 95% confidence interval [CI], -0.916 to 0.722). APGAR 10 at 5 min (59.6% in homeopathy group and 36.4% among control) was statistically significant (P = .016). Conclusions Homeopathy does not appear to prevent excessive body mass gain in pregnant women who are overweight or obese and suspected of having a common mental disorder. Homeopathy did not change the APGAR score to modified clinical attention at delivery room. However, the evidence observed at APGAR 10 at minute 5 suggests that homeopathy had a modulating effect on the vitality of newborns, warranting further studies designed to investigate it.
Palavras-chave
URI
https://observatorio.fm.usp.br/handle/OPI/17978
Referências
  1. Allison DB, 2000, MED CLIN N AM, V84, P305, DOI 10.1016/S0025-7125(05)70223-6
  2. Altman D., 1999, PRACTICAL STAT MED R, P440
  3. American Psychiatric Association, 1994, DIAGN STAT MAN MENT
  4. Annas GJ, 2009, NEW ENGL J MED, V360, P2050, DOI 10.1056/NEJMp0901474
  5. Atalah E, 1997, REV MED CHILE, V125, P1429
  6. Becker ES, 2001, INT J OBESITY, V25, pS5, DOI 10.1038/sj.ijo.0801688
  7. BOARDLEY DJ, 1995, OBSTET GYNECOL, V86, P834, DOI 10.1016/0029-7844(95)00283-W
  8. BRADLEY PJ, 1985, APPETITE, V6, P235
  9. Chong DSY, 2004, ACTA PAEDIATR, V93, P53, DOI 10.1080/08035250310007295
  10. Coggon D, 2005, INT J EPIDEMIOL, V34, P949, DOI 10.1093/ije/dyi012
  11. de Leon J, 2012, J CLIN PSYCHOPHARM, V32, P153, DOI 10.1097/JCP.0b013e3182491383
  12. Romero MD, 2010, STEROIDS, V75, P20, DOI 10.1016/j.steroids.2009.09.009
  13. Gore SA, 2003, ANN BEHAV MED, V26, P149, DOI 10.1207/S15324796ABM2602_07
  14. GREENOUGH A, 1987, ACTA PAEDIATR SCAND, V76, P54, DOI 10.1111/j.1651-2227.1987.tb10414.x
  15. Iacoponi E., 1990, THESIS
  16. Kartvelishvili HIu, 1997, LIK SPRAVA, V1997, P47
  17. Kasysville Hintze, 2000, PASS POWER ANAL SAMP
  18. Katzelnick DJ, 2001, J CLIN PSYCHIAT, V62, P11
  19. Kent JT, 2002, MAT MED, P946
  20. Kiel DW, 2007, OBSTET GYNECOL, V110, P752, DOI 10.1097/01.AOG.0000278819.17190.87
  21. Krasovec K, 1990, NUTR MATERNA RESULTA
  22. Lamothe J., 1993, REV HOMEOPATICA, V9, P27
  23. Lathoud, 1989, MAT MED HOMEOPATICA, V868
  24. Lederman S A, 2001, J Am Med Womens Assoc, V56, P53
  25. Lederman Sally Ann, 2002, Matern Child Health J, V6, P37, DOI 10.1023/A:1014364116513
  26. Linne Y, 2002, Obes Rev, V3, P75, DOI 10.1046/j.1467-789X.2002.00061.x
  27. Lyard RB., 1991, J CLIN PSYCHIAT, V52, P48
  28. MARI JD, 1985, PSYCHOL MED, V15, P651
  29. Mathie Robert T, 2014, Syst Rev, V3, P142, DOI 10.1186/2046-4053-3-142
  30. Mathie RT, 2012, BMC MED RES METHODOL, V12, DOI 10.1186/1471-2288-12-49
  31. McGinty EE, 2016, SCHIZOPHRENIA BULL, V42, P96, DOI 10.1093/schbul/sbv101
  32. Mendonca D, 1997, J BRAS GINEC, V107, P6
  33. Ministerio da Saude, 2005, GUIA AL POP BRAS
  34. Nilson E, LANCET, V182, P1241
  35. O'Donnell CPF, 2006, J PEDIATR-US, V149, P486, DOI 10.1016/j.jpeds.2006.05.010
  36. Oberbaum M, 2005, COMPLEMENT THER MED, V13, P87, DOI 10.1016/j.ctim.2005.03.006
  37. PARKER JD, 1993, OBSTET GYNECOL, V81, P768
  38. Pittler MH, 2005, INT J OBESITY, V29, P1030, DOI 10.1038/sj.ijo.0803008
  39. Polley BA, 2002, INT J OBESITY, V26, P1494, DOI 10.1038/sj.ijo.0802130
  40. POTTER S, 1991, J AM DIET ASSOC, V91, P441
  41. Pustiglione M, 2001, MODERNO ORGANON ARTE
  42. Rached-Paoli I, 2005, ARCH LATINOAM NUTR, V55, P42
  43. Sato C, 2012, HOMEOPATHY, V101, P68, DOI 10.1016/j.homp.2011.09.004
  44. Schauberger C, 1999, OBSTET GYNECOL NEONA, V28, P9
  45. SCHOLL TO, 1995, OBSTET GYNECOL, V86, P423, DOI 10.1016/0029-7844(95)00190-3
  46. Schulz KF, CONSORT 2010 STATEME
  47. Steyer TE, 2009, PRIMARY CARE, V36, P395, DOI 10.1016/j.pop.2009.01.011
  48. Strong K, 2005, LANCET, V366, P1578, DOI 10.1016/S0140-6736(05)67341-2
  49. Summerville R, 2015, CLIN OBES, V5, P12
  50. Toschi-Dias E, 2013, EUR J APPL PHYSIOL, V113, P671, DOI 10.1007/s00421-012-2476-8
  51. Vandenbroucke JP, 2001, ANN INTERN MED, V134, P330
  52. Vannier L, 2004, MANUAL TERAPEUTICA H
  53. Verhaak PFM, 2005, SOC SCI MED, V60, P789, DOI 10.1016/j.socscimed.2004.06.012
  54. Vijayakar P., 2003, HOMEOPATIA PREVISIVE, P222
  55. Vijnovsky B., 1992, TRATADO MAT MED HOME
  56. Vijnovsky B., 1982, HOMEOPATIA BUENOS AI, V48, P23
  57. Vilhena EC., 2004, THESIS
  58. Warffarn F, 2012, AM J OBSTET GYNECOL, V207, P446
  59. Warren KA, 2012, RESP PHYSIOL NEUROBI, V184, P9, DOI 10.1016/j.resp.2012.07.004
  60. Williams Ellen P, 2015, Curr Obes Rep, V4, P363, DOI 10.1007/s13679-015-0169-4
  61. YoubicierSimo BJ, 1996, INT J IMMUNOPATH PH, V9, P43
  62. Zhang S, 2010, FASEB J, V24, P2772, DOI 10.1096/fj.09-154294
  63. Zugaib M, 2008, OBSTETRICIA

Coleções
Artigos e Materiais de Revistas Científicas - FM/MPR
Artigos e Materiais de Revistas Científicas - LIM/39
Artigos e Materiais de Revistas Científicas - ODS/03